Homepage
Author:
Transposon Therapeutics, Inc
Posted Date:
March 4, 2026
Transposon Therapeutics’ TPN-101 to be Studied for Extending Healthy Aging under ARPA-H Award for up to $22M
Transposon Therapeutics, Inc
March 4, 2026